Medicines A–Z
I
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
![]() |
Ingenol mebutate (Picato®) | ||
![]() |
Inotuzumab ozogamicin (Besponsa®) | ||
![]() |
Insulin actrapid® injection (10ml) |
Prescribe by brand name |
|
![]() |
Insulin aspart (Fiasp®) |
Prescribe by brand name. For specialist use in pregnancy. |
|
![]() |
Insulin aspart (Novorapid®) injection |
Prescribe by brand name |
|
![]() |
Insulin degludec 100 units/ml (Tresiba®) |
Amber for type 1 diabetes- specialist initiation. RICaD. Red for Type 2 diabetes. |
|
![]() |
Insulin degludec 100 units/ml (Tresiba®)#red |
Amber for type 1 diabetes- specialist initiation. RICaD. Red for Type 2 diabetes. |
|
![]() |
Insulin detemir (Levemir®) |
Prescribe by brand name |
|
![]() |
Insulin glargene 300 units/ml (Toujeo®) |
Specialist initiation. For patients who require more than 80 units of insulin glargine per day and who are troubled by nocturnal hypos. Transfer to Primary Care should not happen until specialists can demonstrate reduction in nocturnal hypos (e.g. after 3–4 months). RICaD. |
|
![]() |
Insulin glargine (lantus®) |
Extremely high relative cost. Prescribe by brand name. |